Media-OutReach Newswire Novel Chinese medicine for constipation developed by HKBU authorised by U.S. FDA for clinical trial
Society Hospital's neonatology dept recognised for its expert care of premature, low birth-weight babies
2023 VinFuture Special Prize Laureate Prof. Daniel Drucker: Ample room remains for innovation in GLP-1 therapies 2.
Bora Pharmaceuticals Exits Integration Phase with Sequentially-Improved Gross and Operating Margins 5.